The aim of this thesis was to introduce the intrathecal baclofen delivery method and assessment of its efficacy on patients with severe spasticity. It is an invasive spasticity affecting method which uses an abdominally implanted programmable infusion pump connected with a catheter inserted in the spinal canal. The pump delivers baclofen to the cerebrospinal fluid (baclofen is the central myorelaxans). This method reduces adverse effects of the drug, however it is an invasive method, that can bring various complications. In the practical part, I evaluated one patient with spinal spasticity before and after the treatment initiation. The spasm frequency was decreased by 2 points. The muscular tone measured by the Ashworth scale was decreased ...
The neuromotor techniques do not have good results in severe spasticity prevention and treatment (As...
SIGLEAvailable from British Library Document Supply Centre-DSC:4224.84956(no 06/2000) / BLDSC - Brit...
Objective. Intrathecal baclofen (ITB) has become the first choice in the management of deleterious s...
Spasticity may cause immobility, prostration, chronic pain, bedsores, infections, thrombosis and pne...
The purpose of this article is to review the literature on the effects of intrathe-cal[v administere...
Continuous delivery of intrathecal baclofen via an implantable pump was first used to treat severe i...
AimsIntrathecal baclofen (ITB) has proven to be an effective and safe treatment for severe spasticit...
Spasticity can be a serious problem for victims of cerebral and spinal injury. It can interfere with...
In the treatment of patients with severe spasticity, intrathecal administration of baclofen (ITB) wa...
Intrathecal baclofen infusion has demonstrated effectiveness in decreasing spasticity of spinal orig...
Background/Aim. Spasticity is the consequence of several clinical conditions including cerebral pals...
Background/Objective: Intrathecal baclofen (ITB) has been shown to be an effective treatment for sev...
Flexor and extensor spasms associated with severe spasticity frequently cause pain and suffering in ...
OBJECTIVE: To quantitatively assess the antispastic effect of intrathecally administered baclofen on...
Background: Intrathecal Baclofen is available to treat severe generalized spasticity in Multiple Scl...
The neuromotor techniques do not have good results in severe spasticity prevention and treatment (As...
SIGLEAvailable from British Library Document Supply Centre-DSC:4224.84956(no 06/2000) / BLDSC - Brit...
Objective. Intrathecal baclofen (ITB) has become the first choice in the management of deleterious s...
Spasticity may cause immobility, prostration, chronic pain, bedsores, infections, thrombosis and pne...
The purpose of this article is to review the literature on the effects of intrathe-cal[v administere...
Continuous delivery of intrathecal baclofen via an implantable pump was first used to treat severe i...
AimsIntrathecal baclofen (ITB) has proven to be an effective and safe treatment for severe spasticit...
Spasticity can be a serious problem for victims of cerebral and spinal injury. It can interfere with...
In the treatment of patients with severe spasticity, intrathecal administration of baclofen (ITB) wa...
Intrathecal baclofen infusion has demonstrated effectiveness in decreasing spasticity of spinal orig...
Background/Aim. Spasticity is the consequence of several clinical conditions including cerebral pals...
Background/Objective: Intrathecal baclofen (ITB) has been shown to be an effective treatment for sev...
Flexor and extensor spasms associated with severe spasticity frequently cause pain and suffering in ...
OBJECTIVE: To quantitatively assess the antispastic effect of intrathecally administered baclofen on...
Background: Intrathecal Baclofen is available to treat severe generalized spasticity in Multiple Scl...
The neuromotor techniques do not have good results in severe spasticity prevention and treatment (As...
SIGLEAvailable from British Library Document Supply Centre-DSC:4224.84956(no 06/2000) / BLDSC - Brit...
Objective. Intrathecal baclofen (ITB) has become the first choice in the management of deleterious s...